Image by Getty Images via Daylife
Arizona’s scientists and citizens are missing out on a potential lucrative source of research funds and medical benefits because of the state’s strict limits on embryonic stem-cell research, a top biotechnology official said.
James Greenwood, president of the Washington, D.C.-based Biotechnology Industry Organization, said that Arizona and other states that limit such research methods may not realize the benefits from President Barack Obama’s move earlier this month to reverse a ban on federal funding of the controversial research.
“That seems to be a no-brainer,” Greenwood said Friday of allowing research of stem cells that are harvested
A growing trend in USA takes some desperate Americans, unhappy with the US law, travel far away up to China and Thailand, for treatments they hope will help them.
“More funds are necessary for research on amyotrophic lateral sclerosis (ALS). More resources to aid more serious and controlled research for cures that slow the degenerating effects of the disease, for example using stem cells”, said Claudio Sabelli, an ALS patient and member of the Board of the ‘Viva la Vita’ society, writing with a visually controlled computer that communicates for him, commenting about announcements on research to fight ALS.
Sabelli said, “As a patient, I have an opinion that is not supported by facts for the simple reason that there are no new developments. I
What are mesenchymal stem cells? where are they found in the human body? What are their most promising clinical applications? Gordana Vunjak-Novakovic of Columbia University gives us an answer to these questions and and an outlook on the future of mesenchymal stem cells.
Sir John Gurdon
One of the most prestigious prizes in medicine is being awarded this year to scientists working on stem cells and leukemia — and to New York‘s mayor for his fight to cut tobacco use (…)
The Lasker Basic Medical Research Award goes to John Gurdon, 76, of Cambridge University and Shinya Yamanaka, 47, of Kyoto University and San Francisco‘s Gladstone Institute of Cardiovascular Disease. Their work has helped pave the way for the possibility of made-to-order stem cell treatments for individual patients
Gurdon began working with frog eggs in the 1950s and was the first to successfully clone